Get the Stockscreener App
525.28
0.13%
-0.66
After Hours:
527.99
2.71
+0.52%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corporation stock is traded at $525.28, with a volume of 825.83K.
It is down -0.13% in the last 24 hours and up +8.21% over the past month.
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$525.94
Open:
$529.33
24h Volume:
825.83K
Relative Volume:
0.82
Market Cap:
$68.13B
Revenue:
$313.75B
Net Income/Loss:
$2.96B
P/E Ratio:
20.75
EPS:
25.31
Net Cash Flow:
$3.26B
1W Performance:
+5.23%
1M Performance:
+8.21%
6M Performance:
-0.68%
1Y Performance:
+16.02%
1-Day Range:
$520.20
$529.50
1-Week Range:
$492.39
$529.50
52-Week Range:
$431.35
$637.51
Mckesson Corporation Stock (MCK) Company Profile
Name
Mckesson Corporation
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corporation Stock (MCK) Latest News
McKesson Subsidiary Resolves Discrimination Claims for $448,000 - Bloomberg Law
Dallas-area healthcare company to pay to resolve alleged hiring bias - The Dallas Morning News
Is McKesson Corporation (MCK) the Best Pharma Stock to Buy Right Now? - Insider Monkey
McKesson Inks $450K DOL Deal Following Hiring Bias Probe - Law360
McKesson division pays nearly $450K in back wages for alleged hiring discrimination - The Business Journals
Medical supply company McKesson to pay more than $400K over discriminatory hiring - UPI News
Should You Buy, Sell or Hold McKesson Before Q2 Earnings? - Yahoo Finance
McKesson stock falls after company misses quarterly revenue - MSN
Federal contractor agrees to pay more than $448,000 to resolve hiring discrimination stemming from a Grapevine facility - WFAA.com
McKesson Corp. subsidiary to pay $448K in back wages, interest to resolve alleged systemic racial hiring discrimination in Grapevine - US Department of Labor
10 Best Pharma Stocks To Buy Right Now - Insider Monkey
McKesson Co. (NYSE:MCK) Shares Sold by Gladstone Institutional Advisory LLC - MarketBeat
Private Wealth Partners LLC Sells 13,257 Shares of McKesson Co. (NYSE:MCK) - MarketBeat
Silvant Capital Management LLC Reduces Stock Position in McKesson Co. (NYSE:MCK) - MarketBeat
McKesson Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
With 88% ownership of the shares, McKesson Corporation (NYSE:MCK) is heavily dominated by institutional owners - Simply Wall St
McKesson Kickback Case's State Law Claims Axed by Federal Court - Bloomberg Law
Ahead of McKesson (MCK) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
McKesson Co. (NYSE:MCK) Shares Sold by AustralianSuper Pty Ltd - MarketBeat
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
McKesson Co. (NYSE:MCK) to Issue Quarterly Dividend of $0.71 - MarketBeat
McKesson Corporation Declares Quarterly Dividend - StockTitan
First Trust Direct Indexing L.P. Has $2.13 Million Holdings in McKesson Co. (NYSE:MCK) - MarketBeat
McKesson (MCK) Gains As Market Dips: What You Should Know - Yahoo Finance
What the Options Market Tells Us About McKesson - Benzinga
McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Nisa Investment Advisors LLC Purchases 1,678 Shares of McKesson Co. (NYSE:MCK) - MarketBeat
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
McKesson, Cardinal Health draw ire of Sen. Warren over cancer deals - Seeking Alpha
How Is The Market Feeling About McKesson? - Benzinga
Mirae Asset Global Investments Co. Ltd. Grows Stake in McKesson Co. (NYSE:MCK) - MarketBeat
McKesson (MCK) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Do Options Traders Know Something About McKesson (MCK) Stock We Don't? - Yahoo Finance
McKesson to acquire controlling interest in Core Ventures for $2.5B - MSN
Klein Pavlis & Peasley Financial Inc. Acquires 1,188 Shares of McKesson Co. (NYSE:MCK) - MarketBeat
Custom Index Systems LLC Grows Holdings in McKesson Co. (NYSE:MCK) - MarketBeat
Wealth Enhancement Advisory Services LLC Has $88.80 Million Stake in McKesson Co. (NYSE:MCK) - MarketBeat
What is Zacks Research's Estimate for McKesson Q2 Earnings? - MarketBeat
MCK Stock's Uptrend Likely to Continue After Core Ventures Acquisition - MSN
Zacks Research Issues Negative Outlook for McKesson Earnings - MarketBeat
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock - MSN
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
Is McKesson Corporation (NYSE:MCK) the Most Undervalued Value Stock to Buy According to Analysts? - Insider Monkey
Greenleaf Trust Boosts Stock Holdings in McKesson Co. (NYSE:MCK) - MarketBeat
Those who invested in McKesson (NYSE:MCK) five years ago are up 251% - Yahoo Finance
McKesson's Quarterly Earnings Preview: What You Need to Know - MSN
McKesson's Quarterly Earnings Preview: What You Need To Know - Barchart
Jim Cramer on McKesson Corporation (MCK): ‘Buy In A Pyramid Style’ - Insider Monkey
McKesson (FRA:MCK) Forward Dividend Yield % : 0.54% (As of Oct. 22, 2024) - GuruFocus.com
McKesson (FRA:MCK) Total Inventories : €23,755 Mil (As of Jun. 2024) - GuruFocus.com
McKesson (FRA:MCK) Other Current Liabilities : €0 Mil (As of Jun. 2024) - GuruFocus.com
Mckesson Corporation Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
4.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):